News Announcement

Aurobindo Pharma: Outcome of Board Meeting

The Board of Directors of the Company at its meeting held today August 7 2019 has inter alia approved the Un-audited Financial Results of the Company for the first Quarter ended June 30 2019 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

We enclose herewith the said Un-audited Financial Results along with the Limited Review Reports of the Statutory Auditors of the Company.

We also enclose a copy of the Press Release on Un-audited Financial Results of the Company for the first Quarter ended June 30 2019.

The Board meeting commenced at 4.30 p.m and concluded at 6.30 p.m.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.